We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+23.37%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$9.13M
Cap. Flow
-$6.34M
Cap. Flow %
-4.98%
Top 10 Hldgs %
99.52%
Holding
12
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
GNCA
Genocea Biosciences, Inc.
GNCA
+$10

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$5.51M
2
ATYR
aTyr Pharma
ATYR
+$823K

Sector Composition

Rank Sector Weight
1 Healthcare 51.09%
2 Communication Services 46.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDLX icon
1
Cardlytics
CDLX
$22.2M
$59.2M 46.48%
227,734
-27,529
-11% -$5.51M
FATE icon
2
Fate Therapeutics
FATE
$275M
$29.9M 23.49%
1,473,186
– –
KALA icon
3
KALA BIO
KALA
$12.5M
$11.9M 9.31%
744
– –
STIM icon
4
Neuronetics
STIM
$127M
$9.29M 7.29%
742,289
– –
RNAC icon
5
Cartesian Therapeutics
RNAC
$218M
$4.96M 3.9%
92,449
– –
XFOR icon
6
X4 Pharmaceuticals
XFOR
$377M
$4.67M 3.67%
10,383
– –
TTOO
7
DELISTED
T2 Biosystems, Inc
TTOO
$3.09M 2.43%
368
– –
TRVN
8
DELISTED
Trevena, Inc.
TRVN
$2.12M 1.66%
3,286
– –
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$965K 0.76%
246,078
+2
+0% +$10
ATYR
10
aTyr Pharma
ATYR
$47.4M
$670K 0.53%
9,327
-121,244
-93% -$823K
PULM icon
11
Pulmatrix
PULM
$6.1M
$331K 0.26%
17,972
– –
DARE icon
12
Dare Bioscience
DARE
$17.4M
$277K 0.22%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q2 2019 Portfolio in Review

As of Q2 2019, Polaris Venture Management Co V held 12 positions worth $127M, up 7.7% from $118M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $6.34M in Q2 2019, reducing 2 holdings. Its largest reduction was Cardlytics, cutting an estimated $5.51M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 60% a quarter earlier, followed by Communication Services.

Against the trend, Polaris Venture Management Co V added an estimated $10 to Genocea Biosciences, Inc..

  • Polaris Venture Management Co V added most to Genocea Biosciences, Inc. in Q2 2019, an estimated $10 increase.
  • Polaris Venture Management Co V's biggest Q2 2019 reduction was Cardlytics, cutting an estimated $5.51M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $127M portfolio in Q2 2019.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q2 2019.
  • Polaris Venture Management Co V's portfolio value rose 7.7% quarter-over-quarter to $127M.

Based on Polaris Venture Management Co V's 13F filing for Q2 2019, filed 12 Aug 2019.